Pixilab
Home › Companies › SEC Form D - Biotechnology › IMMvention Therapeutix, Inc.

IMMvention Therapeutix, Inc.

SEC Form D private-offering issuer in Biotechnology

Operating in sec form d - biotechnology based in DURHAM, NORTH CAROLINA, IMMvention Therapeutix, Inc. was founded in 2017.

Profile

Private US issuer recorded in the SEC Form D structured dataset for 2020Q4. Industry: Biotechnology. Revenue range: Decline to Disclose. Offering amount: 4402504.

IMMvention Therapeutix, Inc. is positioned in sec form d - biotechnology, a segment that rewards a clear, focused offering.

Its base of operations is DURHAM, NORTH CAROLINA.

Directory data places it at the Regulation D stage.

The company reports a headcount in the 1-10 range.

Total disclosed funding stands at about $4.4M.

SectorSEC Form D - Biotechnology
HeadquartersDURHAM, NORTH CAROLINA
CountryUnited States
Founded2017
Employees1-10
StageRegulation D
Total funding$4,402,504

Website: immventionthera.com

Browse related

More SEC Form D - Biotechnology companies Companies in United States Companies founded in 2017
Full contact details are available to registered Pixilab members.
Create a free account